Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals - Wikidata - wikimedia - TriplyDB

Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals

Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals

http://www.wikidata.org/entity/Q40621942

about

Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis Use of Direct-Acting Antivirals for the Treatment of Hepatitis C Virus-Associated Oral Lichen Planus: A Case Report.Extrahepatic manifestations of HCV: the role of direct acting antivirals.Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.The microbiology of oral lichen planus: Is microbial infection the cause of oral lichen planus?Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report.Acyclovir for treatment of lichen planus.Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma.Clinical features and management of oral lichen planus (OLP) with emphasis on the management of hepatitis C virus (HCV)-related OLP

P2860

Q28077287-529A317D-2B84-41F3-8C3F-315FD82AFF32 Q37434933-E436D03D-035E-4474-B5E1-DFBEED458BB7 Q38684508-FC0EE393-4FD0-4F89-86B5-24BC70F3BB5B Q38933599-0DC2B73F-ED06-42F0-AF3C-49E0392B82BC Q40058992-54922984-23CC-4A03-BEFB-577FAC8C5425 Q40225926-C57EFEEF-57A7-423B-AA9B-E12D1F3D18D0 Q48296815-808B17AB-525A-4149-9B56-DB86D57082ED Q49395696-2606A656-B38A-481F-B26A-FD6A9DA1E6D2 Q57005545-EFB8AF4B-DCB5-426E-BACD-C64932ECE82E

P2860

Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals

http://www.wikidata.org/entity/Q40621942

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Successful Treatment of Hepati ...... with Direct-acting Antivirals

@en

type

label

Successful Treatment of Hepati ...... with Direct-acting Antivirals

@en

prefLabel

Successful Treatment of Hepati ...... with Direct-acting Antivirals

@en

P1433

Q40621942-C2151D44-2794-4E2D-ADA7-90906A8DC216

P1476

Q40621942-A5780B75-E1CD-47BD-84FB-F459096A408D

P2093

Q40621942-05CC135E-0F36-4E43-842C-63E54C034FDD

Q40621942-A00AEFE1-0259-4A56-AF2E-6AF5B272184D

Q40621942-A39AB989-5F74-4C9A-92A2-C8885C374A51

Q40621942-B1FA72EC-26BB-44CC-BCCB-EB44B3AC56F3

P2860

Q40621942-023B1133-EF04-477F-94BC-4FFF9DB9F7F8

Q40621942-030A007F-7039-407B-8C90-F08325660A32

Q40621942-0C45C3E3-1CB8-48F8-A7FB-15F428082FE1

Q40621942-0D17FDA5-4BAA-4C38-A340-2B7378260361

Q40621942-0D3A56BA-B3B5-457A-9827-94EAE37931FD

Q40621942-23144303-9F13-4B7D-AB90-36C20383FE1B

Q40621942-381BC08C-8B08-4CB3-AAE9-8EBCE678A2EB

Q40621942-382C4165-777D-4781-8683-3A44C0A4C323

Q40621942-42900468-9ED5-46D7-BE95-EBC9AAD31D43

Q40621942-43E6C655-D780-4F38-B3F6-468BB92817DA

P304

Q40621942-3BA0ACD5-6D29-4D9C-AA03-5225AD41AA0B

P31

Q40621942-FD51FF60-4FE4-41EC-A990-AF4AD8D2DCD5

P356

Q40621942-8EA59419-B54C-4BB4-9A75-CF5E68EC5A17

P433

Q40621942-E825CBB0-03AB-41C3-8480-8431D88B5D60

P478

Q40621942-A4F4B0F9-BE85-40E7-888B-CE0AE3C9A9B9

P577

Q40621942-EBE29802-AEC7-4C01-96F2-8A9849DD582A

P698

Q40621942-939A1195-27B6-45F4-A927-5775A88FB342

P932

Q40621942-308812CA-BAAC-4660-8865-F4532FFFE7D3

P356

P1433

Clinical and translational gastroenterology

P1476

Successful Treatment of Hepati ...... with Direct-acting Antivirals

@en

P2093

Kanae Kimura

http://www.w3.org/2001/XMLSchema#string

Michio Sata

http://www.w3.org/2001/XMLSchema#string

Yuji Kawahigashi

http://www.w3.org/2001/XMLSchema#string

Yumiko Nagao

http://www.w3.org/2001/XMLSchema#string

P2860

An overview of the c-MET signaling pathway

Cutaneous manifestations of hepatitis C in the era of new antiviral agents

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics.

Analysis of the factors motivating HCV-infected patients to accept interferon therapy

Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.

Occurrence of oral leukoplakia and lichen planus in diabetes mellitus.

P304

e179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CTG.2016.37

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27388424

http://www.w3.org/2001/XMLSchema#string

P932

5543481

http://www.w3.org/2001/XMLSchema#string